×
About 1,180 results

ALLMedicine™ Cardioembolic Stroke Center

Research & Reviews  414 results

BNP on Admission Combined with Imaging Markers of Multimodal CT to Predict the Risk of ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9345733
Disease Markers; Cao R, Jiang Y et. al.

Aug 6th, 2022 - The aim of the study was to find the potential roles of B-type natriuretic peptide (BNP) and imaging markers on distinguishing cardioembolic (CE) stroke from non-CE stroke, so as to provide useful information for making individualized endovascular...

Atrial cardiomyopathy: from cell to bedside.
https://doi.org/10.1002/ehf2.14089
ESC Heart Failure; Li M, Ning Y et. al.

Aug 4th, 2022 - Atrial cardiomyopathy refers to structural and electrical remodelling of the atria, which can lead to impaired mechanical function. While historical studies have implicated atrial fibrillation as the leading cause of cardioembolic stroke, atrial c...

Keeping Oral o Parental AnticoaguLation in the Acute Phase of Cardioembolic Ischemic Stroke
https://clinicaltrials.gov/ct2/show/NCT05486351

Aug 3rd, 2022 - Observational, prospective, multicenter, cohort study in patients with recent cardioembolic stroke (<24 hours) and previous oral or parenteral anticoagulant therapy (last dose recieved <24hours) . Patients in which anticoagulante therapy is mantai...

Electrocardiogram analysis of post-stroke elderly people using one-dimensional convolut...
https://doi.org/10.1016/j.artmed.2022.102342
Artificial Intelligence in Medicine; Ho ES, Ding Z

Jul 10th, 2022 - Stroke is the second leading cause of death globally after ischemic heart disease, also a risk factor of cardioembolic stroke. Thus, we postulate that heartbeats encapsulate vital signals related to stroke. With the rapid advancement of deep neura...

Treatment in stroke unit and risk factor control reduce recurrent stroke risk.
https://doi.org/10.1159/000525716
Cerebrovascular Diseases Extra; Shani SD, Varma RP et. al.

Jul 7th, 2022 - The risk factor control is an important predictor of risk of stroke recurrence. The attributable fraction which estimates the excess risk among the exposed stroke survivors has not been studied previously. We studied the attributable fraction for ...

see more →

Clinicaltrials.gov  18 results

Keeping Oral o Parental AnticoaguLation in the Acute Phase of Cardioembolic Ischemic Stroke
https://clinicaltrials.gov/ct2/show/NCT05486351

Aug 3rd, 2022 - Observational, prospective, multicenter, cohort study in patients with recent cardioembolic stroke (<24 hours) and previous oral or parenteral anticoagulant therapy (last dose recieved <24hours) . Patients in which anticoagulante therapy is mantai...

Translational Immunodiagnostics in Stroke (TrImS)
https://clinicaltrials.gov/ct2/show/NCT05300997

Jul 6th, 2022 - Introduction Stroke is a leading cause of overall mortality, morbidity and disability worldwide. In 2010 it was the second leading cause of death whilst in 2019 it ranked third overall for disability adjusted life years (DALYs) and second for thos...

Comparison of Amplatzer Amulet and Watchman Device in Patients Undergoing Left Atrial Appendage Closure. (SWISS-APERO)
https://clinicaltrials.gov/ct2/show/NCT03399851

Mar 28th, 2022 - Non-valvular Atrial fibrillation (NVAF) is the most common cardiac arrhythmia and a major cause of morbidity and mortality because of cardioembolic stroke. Oral anticoagulation (OAC) with vitamin K antagonists (VKA) or Non-vitamin K antagonist ant...

Validation of 3D Simulations in Embolic Stroke
https://clinicaltrials.gov/ct2/show/NCT05055960

Feb 28th, 2022 - Stroke affects more than 100 000 people each year in the UK, and up to 50% of patients are left with significant disability [1, 2]. 85% of strokes result from occluded blood vessels in the brain (acute ischaemic stroke [AIS]), interrupting the blo...

Intraventricular Stasis In Cardiovascular Disease
https://clinicaltrials.gov/ct2/show/NCT04649034

Feb 4th, 2022 - Cardioembolic stroke is a major source of mortality and disability worldwide and blood stasis inside the heart is the main risk factor for developing intracardiac thrombosis. We have recently developed and patented a quantitative image-based metho...

see more →

News  40 results

Ticagrelor Steps It Up for Stroke Patients With Impaired Clopidogrel Metabolism
https://www.medpagetoday.com/cardiology/strokes/95304

Oct 28th, 2021 - Stroke survivors carrying CYP2C19 loss-of-function alleles had better secondary prevention when taking ticagrelor (Brilinta) versus clopidogrel (Plavix) as an add-on to aspirin, according to the Chinese CHANCE-2 trial. Subsequent ischemic or hemor...

Intracranial Atherosclerosis Finding on MRA Linked to Stroke
https://www.medscape.com/viewarticle/955993

Aug 4th, 2021 - An incidental diagnosis of intracranial atherosclerotic stenosis in stroke-free individuals should trigger a thorough assessment of vascular health, according to the authors of a study identifying risk factors and vascular event risk in asymptomat...

Small Complicated Carotid Plaques May Be Culprit in Some Strokes
https://www.medscape.com/viewarticle/940555

Nov 6th, 2020 - The presence of certain complicating features on plaques in the carotid artery are an under-recognized cause of ischemic stroke, a new study suggests. The CAPIAS (Carotid Plaque Imaging in Acute Stroke) study showed that complicated nonstenosing c...

Microbleeds Shouldn't Influence Anticoagulation After Stroke
https://www.staging.medscape.com/viewarticle/939630

Oct 22nd, 2020 - The presence of microbleeds in the brain should not affect the decision to prescribe anticoagulation to patients after an ischemic stroke, new data suggest. The new results come from a prespecified substudy of the NAVIGATE-ESUS trial, which compar...

Microbleeds Shouldn't Influence Anticoagulation After Stroke
https://www.medscape.com/viewarticle/939630

Oct 22nd, 2020 - The presence of microbleeds in the brain should not affect the decision to prescribe anticoagulation to patients after an ischemic stroke, new data suggest. The new results come from a prespecified substudy of the NAVIGATE-ESUS trial, which compar...

see more →